Dexamethasone phosphate (as sodium); 4mg/mL, 10mg/mL; soln for IV or IM inj; contains sulfites. Potentiated by CYP3A4 inhibitors (eg, ketoconazole, macrolides), cyclosporine, estrogens.

and intravenous dexamethasone (0.15 mg/kg to a maximum of 16 mg, slowly), in group I and II, respectively. Pain explained by patients, based on VAS (Visual Analogue Scale) was recorded at the time ...

Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.

Approved Indications of SNY's Sarclisa IV Sarclisa, in combination with Bristol Myers’ Pomalyst and dexamethasone, is approved to treat adult patients with MM who have received at least two ...

Approved Indications of SNY's Sarclisa IV Sarclisa, in combination with Bristol Myers’ Pomalyst and dexamethasone, is approved to treat adult patients with MM who have received at least two ...

The mean age of patients treated with dexamethasone was 36.27 ± 13.38 and in group treated with intravenous propofol was 35.65 ± 12.55 years. Independent T-test results showed no significant ...